Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Shattuck Labs Inc (STTK)

Shattuck Labs Inc (STTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Shattuck Labs Inc 500 W. 5TH STREET SUITE 1200 AUSTIN TX 78701 USA

www.shattucklabs.com Employees: 44 P: 512-900-4690

Sector:

Medical

Description:

Shattuck Labs Inc. is a clinical-stage biotechnology company. It engages in development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of cancer and autoimmune disease. The company's wholly owned program includes SL-172154. It operates principally in Durham, North Carolina and Austin, Texas. Shattuck Labs Inc. is based in Austin, United States.

Key Statistics

Overview:

Market Capitalization, $K 293,619
Enterprise Value, $K 236,229
Shares Outstanding, K 63,280
Float, K 55,686
% Float 88.00%
Short Interest, K 743
Short Float 1.17%
Days to Cover 1.43
Short Volume Ratio 0.26
% of Insider Shareholders 12.00%
% of Institutional Shareholders 58.74%

Financials:

Annual Sales, $ 5,720 K
Annual Net Income, $ -75,410 K
Last Quarter Sales, $ 1,000 K
Last Quarter Net Income, $ -10,060 K
EBIT, $ -57,780 K
EBITDA, $ -56,100 K

Growth:

1-Year Return 325.69%
3-Year Return 62.81%
5-Year Return -90.72%
5-Year Revenue Growth -42.16%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 11/06/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -1.02
EPS Growth vs. Prev Qtr 41.67%
EPS Growth vs. Prev Year 57.58%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

STTK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -73.82%
Return-on-Assets % -65.96%
Profit Margin % -1,318.36%
Debt/Equity 0.00
Price/Sales 261.17
Price/Cash Flow N/A
Price/Book 3.03
Book Value/Share 1.47
Interest Coverage -2.95
60-Month Beta 1.53
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar